Aapro, M S <br/><br/>
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Oct 2006 
 - 2433-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2006.05.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Male<br/>Neoplasms--drug therapy<br/>Neutropenia--chemically induced<br/>Recombinant Proteins<br/>Risk Factors